Next Article in Journal
CYP1A2 mRNA Expression Rather than Genetic Variants Indicate Hepatic CYP1A2 Activity
Next Article in Special Issue
Inclusion of a Phytomedicinal Flavonoid in Biocompatible Surface-Modified Chylomicron Mimic Nanovesicles with Improved Oral Bioavailability and Virucidal Activity: Molecular Modeling and Pharmacodynamic Studies
Previous Article in Journal
Advances in the Prophylaxis of Respiratory Infections by the Nasal and the Oromucosal Route: Relevance to the Fight with the SARS-CoV-2 Pandemic
Previous Article in Special Issue
Moxifloxacin Liposomes: Effect of Liposome Preparation Method on Physicochemical Properties and Antimicrobial Activity against Staphylococcus epidermidis
 
 
Review

Article Versions Notes

Pharmaceutics 2022, 14(3), 531; https://doi.org/10.3390/pharmaceutics14030531
Action Date Notes Link
article xml file uploaded 27 February 2022 10:56 CET Original file -
article xml uploaded. 27 February 2022 10:56 CET Update https://www.mdpi.com/1999-4923/14/3/531/xml
article pdf uploaded. 27 February 2022 10:56 CET Version of Record https://www.mdpi.com/1999-4923/14/3/531/pdf
article html file updated 27 February 2022 10:57 CET Original file -
article html file updated 1 August 2022 03:07 CEST Update https://www.mdpi.com/1999-4923/14/3/531/html
Back to TopTop